Business · 1 sources covering this

Jefferies Hikes Max Healthcare Price Target, Expects Oncology Drug Woes To Fade By December

Max Healthcare discontinued its high-value patented chemotherapy drugs for institutional patients earlier this year after the Central government capped pricing.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·1h ago
Jefferies Hikes Max Healthcare Price Target, Expects Oncology Drug Woes To Fade By December
Max Healthcare discontinued its high-value patented chemotherapy drugs for institutional patients earlier this year after the Central government capped pricing.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/33a4fb85211ac418ef52983f0df034b9b4038c04"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Jefferies Hikes Max Healthcare Price Target, Expects Oncology Drug Woes To Fade By December"></iframe>

Jefferies Hikes Max Healthcare Price Target, Expects Oncology Drug Woes To Fade By December

How 1 sources are covering this

Jefferies Hikes Max Healthcare Price Target, Expects Oncology Drug Woes To Fade By December

More from Business

Stock markets decline in early trade amid rising crude oil prices

Jharkhand protest: Round 7 of talks with Govt on day 16 of hunger strike today - what's the latest?

Census 2027 population count begins in J&K, Ladakh: Here's what we know

Son wins 54F tax case on inherited land from mother

Reader

Trust & legal

Across the network